Jean-Pascal MACCHI Appointed New CEO of IKOULA
After joining the SEWAN group at the end of September 2021, IKOULA is starting a new chapter in its history, by announcing the arrival of Jean-Pascal MACCHI as CEO.
With more than 20 years of experience in the world of web hosting and telecoms, Jean-Pascal will take charge of the complete management of IKOULA and its subsidiaries in the Netherlands and Spain. His objective will be to support the company in its development both externally and internally within the SEWAN group, and to strengthen its position among the European Cloud leaders.
“We are delighted to welcome Jean-Pascal into the SEWAN group, and more particularly as the CEO of IKOULA,” commented Alexis de Goriainoff, co-founder and CEO of SEWAN. “His solid experience acquired among others at Hexanet and Adista make Jean-Pascal the ideal person to take the reins of IKOULA and put to music the synergies that already exist with SEWAN.”
"Being based in the Reims region, I have known IKOULA since its creation, and have carefully followed its development, masterfully led by Jules-Henri Gavetti and Caroline Mertens", continues Jean-Pascal Macchi. “At a time when the Cloud and other unified communication solutions are more than ever at the heart of business strategies, the opportunities arising from the SEWAN – IKOULA merger look very promising. In addition, the values advocated by IKOULA - and shared by SEWAN - totally echo mine: innovation, proximity, quality of service and support. This is why I am proud to be able to take up the torch of this wonderful company, and am more than ever looking forward to pooling my expertise with that of the Ikoulians, to build the professional solutions of tomorrow. »
Biography:
2019 – 2021 : Deputy Managing Director of Trekk & Résoprint
2015 – 2019 : Chief Operating Officer, then CEO of Adista
2001 – 2015 : CEO of Hexanet
1999-2001 : Head of Sales at Euralliance
Preparatory year for HEC & SUP DE CO / ESG Management School
About IKOULA
Pioneer of the French Cloud since 1998, IKOULA has its own Datacenters in France, as well as two subsidiaries, in Spain and in the Netherlands. Because people are part of its DNA, IKOULA maintains a close relationship with its customers, and provides them with teams of experts available 24/7, to advise and support them in their activities. IKOULA's teams are also multilingual, in order to respond to the internationalization issues of all of its customers, located in more than 60 countries on 4 continents. Since September 2021, IKOULA has joined of the SEWAN Group.
About Sewan
A French telecoms scale-up created in 2007 by Alexis de Goriainoff, David Brette and Christophe Cresp, Sewan aims to simplify the use of corporate communications. To do this, Sewan offers three families of products dedicated to Communication, Connectivity and Data Hosting, which can be ordered, invoiced and configured from a single interface, called Sophia. From small businesses to large groups, Sewan's offer adapts to all the needs of a professional world with constantly changing working methods. Today a major pan-European player, Sewan has 700 employees and more than a million end users, spread over 4 countries: France, Spain, Belgium and Germany. Sewan also has a network of more than 1,000 partners and 75,000 customers.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220120005007/en/
Contact information
Press Contacts
Laurane VASSOR ARCARO
+33 1 84 01 02 69
lvassorarcaro@ikoula.com
Océane FIEU – Fiona THOMAS
06 79 58 01 81 – 06 61 73 98 18
oceane@agence-leon.fr
fiona@agence-leon.fr
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Daiichi Sankyo Announces the Initiation of the Development of Oral Triple Combination Lipid-Lowering Tablets to Support the Management of LDL-C30.8.2025 19:00:00 EEST | Press release
Daiichi Sankyo Europe is pleased to announce the initiation of the development of new oral triple combination tablets in Europe of bempedoic acid, ezetimibe, and different doses of a statin (atorvastatin or rosuvastatin), with the potential to lower low-density lipoprotein cholesterol (LDL-C) levels.9 It is well known that combination therapies reduce the pill burden for patients, potentially enhancing treatment adherence and facilitating treatment with a goal of improving cardiovascular outcomes.9,10 “As bempedoic acid and ezetimibe are already approved as a single-dose therapy, the development of an oral triple combination tablet with different doses of a statin, can make it easier for physicians to tailor treatment to the individual needs of each patient,” says Dr. Stefan Seyfried, Vice President and Head Medical Affairs Specialty Medicines, Daiichi Sankyo Europe. “This approach exemplifies our dedication to our motto: ‘we care for every heartbeat’.” “The management of dyslipidaemia
Alnylam to Advance Zilebesiran into Global Phase 3 Cardiovascular Outcomes Trial30.8.2025 17:30:00 EEST | Press release
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced plans to initiate a Phase 3 cardiovascular outcomes trial (CVOT) to evaluate the potential of zilebesiran to reduce the risk of major adverse cardiovascular events. This decision is informed by results from the comprehensive KARDIA Phase 2 program, including KARDIA-3 results presented today as a late-breaking abstract at the European Society of Cardiology (ESC) Congress in Madrid, Spain. Zilebesiran is an investigational subcutaneously administered RNAi therapeutic which, in the KARDIA Phase 2 program, has shown reductions in blood pressure by targeting liver-expressed angiotensinogen (AGT), the most upstream precursor in the Renin-Angiotensin-Aldosterone System (RAAS), which plays a key role in blood pressure regulation and impacts cardiovascular and renal health. KARDIA-3, the third Phase 2 study in the KARDIA program, evaluated the efficacy and safety of zilebesiran in patients with
BeOne Medicines Announces Positive Topline Results for Sonrotoclax in Relapsed or Refractory Mantle Cell Lymphoma (MCL)29.8.2025 13:00:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced positive topline results from a Phase 1/2 study (BGB-11417-201) of sonrotoclax, a next-generation and potentially best-in-class investigational BCL2 inhibitor, in adult patients with relapsed/refractory (R/R) mantle cell lymphoma (MCL), following treatment with a Bruton’s tyrosine kinase inhibitor (BTKi) and anti-CD20 therapy. BeOne plans to present the full data at an upcoming medical meeting. “For people with relapsed or refractory mantle cell lymphoma, the disease is aggressive, the treatment landscape fragmented, and the outcomes unacceptably poor. These topline results for sonrotoclax underscore its potential to deliver meaningful and durable responses and offer the first BCL2 inhibitor for patients with R/R MCL, if approved,” said Lai Wang, PhD, Global Head of R&D, BeOne Medicines. “These data add to the remarkable progress we’ve seen over the past five years in treating B-cel
Oulu2026 – European Capital of Culture: Oulu to Unveil Full European Capital of Culture 2026 Programme – Live Stream on 4 September 202529.8.2025 11:46:00 EEST | Press release
Hundreds of partners are creating a year in which Northern Finland becomes a new hub of culture. The programme will offer something for everyone: large-scale exhibitions, festivals across all genres, world premieres, performing arts, village celebrations, permanent artworks, sports, and community events across a vast region of 40 municipalities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250829591577/en/ Oulu, with its 39 partner municipalities in Northern Finland, will step into the spotlight as European Capital of Culture 2026. The full programme will be officially launched on Thursday 4 September 2025 in Oulu, streamed live across Europe. The Oulu2026 programme is built around the theme of Cultural Climate Change, meaning a lasting enrichment of cultural life – connecting people through world-class experiences, creativity, and new ways of thinking. “2026 will be a transformative year – for our city, for Northern Finla
Nippon Sanso Holdings Group Unifies Global Brand Logo Launching the "NIPPON SANSO" Brand Worldwide29.8.2025 09:00:00 EEST | Press release
Nippon Sanso Holdings Corporation (President CEO: Toshihiko Hamada) will unify the brand logo for its industrial gas business globally and implement the change in stages. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250828253560/en/ Until now, our group has operated industrial gas businesses worldwide using the same symbol mark, while adapting to each region. To further enhance recognition and understanding of our group as a unified entity among a broad range of stakeholders, and to maximize corporate value and achieve sustainable growth, we have decided to unify the brand for our industrial gas businesses as "NIPPON SANSO" and standardize the brand logo globally. Moving forward, we will continue striving to be a trusted company for all stakeholders as a globally recognized brand. *Please note that Thermos Group, which operates the consumer household goods business within our group, will not change its brand logo. *The log
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom